GlassScriptPhysician profile
Christopher C Saccone
NPI 1083029235
$1,148.97
in general payments reported to CMS, 2019-2025
19 companies · $311 in 2025
The $311 reported for 2025 was less than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $207 · 2020: $45.99 · 2021: $55.84 · 2022: $115 · 2023: $262 · 2024: $152 · 2025: $311.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $726.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $725.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $323.29 | 2023-2025 | Iconix, Augment Injectable, Ortholoc 3di |
| Bone Support INC. | $129.47 | 2022-2025 | Cerament G, Ceramentbone Void Filler |
| Organogenesis INC. | $125.38 | 2020-2023 | Puraply |
| Melinta Therapeutics, LLC | $116.01 | 2019 | |
| Smith+Nephew, INC. | $75.26 | 2023-2024 | Grafix Pl, Stravix |
| Bioventus LLC | $61.13 | 2019-2023 | Exogen Ultrasound Bone Healing System |
| Zyla Life Sciences, INC. | $51.26 | 2019 | |
| Medartis INC. | $34.92 | 2019-2021 | |
| Blue Surgical LLC | $34.28 | 2025 | |
| Horizon Therapeutics Plc | $31.79 | 2021-2023 | Krystexxa |
| Kerecis Limited | $26.49 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide, Kerecis Omega3 Surgiclose |
| Treace Medical Concepts, INC. | $26.38 | 2025 | |
| Abbvie INC. | $19.75 | 2025 | |
| Amgen INC. | $17.76 | 2024 | Krystexxa |
| Orthofix Medical, INC. | $17.66 | 2020-2021 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $16.03 | 2023 | Intellis Adaptivestim |
| Paragon 28, INC. | $15.55 | 2023 | |
| Abbott Laboratories | $13.83 | 2021 | |
| Assertio Therapeutics, INC. | $12.73 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Saccone listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.